🇺🇸 FDA

Drug profile · INN

midazolam hydrochloride

MIDAZOLAM HYDROCHLORIDE

approved
US status
approved
Patents linked
2
News articles
0

Quick answer

midazolam hydrochloride (MIDAZOLAM HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.

Key facts

INN midazolam hydrochloride
Brand MIDAZOLAM HYDROCHLORIDE
Route INTRAMUSCULAR
Formulation INJECTABLE

Related patents

Search patents →

  1. US 8420072

    Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 6706754

    Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis

    Expires Mon Mar 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is midazolam hydrochloride?

midazolam hydrochloride (MIDAZOLAM HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular. Current US regulatory status: approved.

What is the brand name for midazolam hydrochloride?

MIDAZOLAM HYDROCHLORIDE is a marketed brand name for midazolam hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of midazolam hydrochloride?

midazolam hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.